aTyr Pharma, Inc.
ATYR
$0.58
$0.024.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -19.15% | -19.15% | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -19.15% | -19.15% | -100.00% |
| Cost of Revenue | 3.65% | -23.02% | -16.94% | -15.30% | -22.29% |
| Gross Profit | -3.16% | 23.38% | 16.93% | 15.29% | 21.37% |
| SG&A Expenses | 7.25% | 24.80% | 27.73% | 29.10% | 24.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.57% | 9.59% | 14.19% | 15.45% | 10.99% |
| Operating Income | 8.84% | -9.30% | -14.30% | -15.57% | -12.03% |
| Income Before Tax | 8.75% | -10.44% | -15.78% | -17.73% | -15.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.75% | -10.44% | -15.78% | -17.73% | -15.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | 25.00% | 600.00% | 600.00% | 600.00% |
| Net Income | 8.75% | -10.43% | -15.77% | -17.72% | -15.10% |
| EBIT | 8.84% | -9.30% | -14.30% | -15.57% | -12.03% |
| EBITDA | 8.89% | -9.46% | -14.52% | -15.79% | -12.20% |
| EPS Basic | 21.91% | 8.93% | 8.32% | 10.90% | 11.89% |
| Normalized Basic EPS | 21.91% | 8.95% | 8.36% | 10.91% | 11.90% |
| EPS Diluted | 21.91% | 8.93% | 8.32% | 10.90% | 11.89% |
| Normalized Diluted EPS | 21.91% | 8.95% | 8.36% | 10.91% | 11.90% |
| Average Basic Shares Outstanding | 16.75% | 20.81% | 25.22% | 30.38% | 31.16% |
| Average Diluted Shares Outstanding | 16.75% | 20.81% | 25.22% | 30.38% | 31.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |